Mingqing Xu

3.6k total citations
147 papers, 2.7k citations indexed

About

Mingqing Xu is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Mingqing Xu has authored 147 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Hepatology, 76 papers in Surgery and 51 papers in Epidemiology. Recurrent topics in Mingqing Xu's work include Hepatocellular Carcinoma Treatment and Prognosis (58 papers), Organ Transplantation Techniques and Outcomes (45 papers) and Liver Disease Diagnosis and Treatment (44 papers). Mingqing Xu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (58 papers), Organ Transplantation Techniques and Outcomes (45 papers) and Liver Disease Diagnosis and Treatment (44 papers). Mingqing Xu collaborates with scholars based in China, United States and Canada. Mingqing Xu's co-authors include Xiaobo Zheng, Liangliang Xu, Wentao Wang, Tianfu Wen, Pengsheng Yi, Lünan Yan, Lvnan Yan, Ming Zhang, Bo Li and Chuan Lan and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Cancer.

In The Last Decade

Mingqing Xu

144 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingqing Xu China 28 1.3k 1000 894 820 732 147 2.7k
Takeo Toshima Japan 31 1.6k 1.2× 1.2k 1.2× 603 0.7× 474 0.6× 1.1k 1.5× 182 3.3k
Kazuki Takeishi Japan 28 1.2k 0.9× 848 0.8× 455 0.5× 335 0.4× 729 1.0× 108 2.4k
Parissa Tabrizian United States 28 1.9k 1.4× 1.4k 1.4× 581 0.6× 331 0.4× 984 1.3× 107 3.3k
Anne Durnez Belgium 14 731 0.5× 436 0.4× 327 0.4× 579 0.7× 483 0.7× 21 1.8k
Hirotaka Tashiro Japan 26 1.5k 1.1× 1.1k 1.1× 209 0.2× 382 0.5× 860 1.2× 214 2.6k
Cheng‐Yuan Hsia Taiwan 31 2.5k 1.9× 1.1k 1.1× 633 0.7× 303 0.4× 1.7k 2.3× 122 3.3k
Anna Skowrońska United Kingdom 13 1.5k 1.1× 424 0.4× 311 0.3× 466 0.6× 1.1k 1.5× 37 2.6k
Yohei Mano Japan 24 807 0.6× 656 0.7× 553 0.6× 306 0.4× 483 0.7× 77 2.1k
Sherrie Bhoori Italy 25 2.6k 1.9× 1.2k 1.2× 352 0.4× 576 0.7× 1.7k 2.3× 58 3.8k
Delia D’Avola Spain 25 1.2k 0.9× 489 0.5× 277 0.3× 396 0.5× 726 1.0× 60 2.1k

Countries citing papers authored by Mingqing Xu

Since Specialization
Citations

This map shows the geographic impact of Mingqing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingqing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingqing Xu more than expected).

Fields of papers citing papers by Mingqing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingqing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingqing Xu. The network helps show where Mingqing Xu may publish in the future.

Co-authorship network of co-authors of Mingqing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingqing Xu. A scholar is included among the top collaborators of Mingqing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingqing Xu. Mingqing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Mingqing, et al.. (2024). Hepatic sarcomatoid carcinoma: A case report and literature review. Asian Journal of Surgery. 47(6). 2954–2955. 2 indexed citations
2.
3.
Li, Lian, Liangliang Xu, Peng Wang, et al.. (2022). Advantages of laparoscopic hepatic hemangioma surgery in quality of life: a prospective study. Surgical Endoscopy. 36(12). 8967–8974. 5 indexed citations
4.
Zheng, Xiaobo, Chune Yu, & Mingqing Xu. (2021). Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy. Frontiers in Oncology. 11. 678333–678333. 46 indexed citations
5.
Li, Lian, Tianfu Wen, Hong Wu, et al.. (2020). Poor Prognoses of Young Hepatocellular Carcinoma Patients with Microvascular Invasion: A Propensity Score Matching Cohort Study. Gastroenterology Research and Practice. 2020. 1–8. 4 indexed citations
6.
Zhang, Jinfu, Liangliang Xu, Peng Wang, et al.. (2020). RNA-seq Used to Explore circRNA Expression and Identify Key circRNAs During the DNA Synthesis Phase of Mice Liver Regeneration. DNA and Cell Biology. 39(11). 2059–2076. 11 indexed citations
7.
Wang, Peng, Liangliang Xu, Xiaobo Zheng, et al.. (2020). Correlation between the expressions of circular RNAs in peripheral venous blood and clinicopathological features in hepatocellular carcinoma. Annals of Translational Medicine. 8(6). 338–338. 14 indexed citations
8.
Xu, Liangliang, Lian Li, Peng Wang, et al.. (2019). Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center. Gut and Liver. 13(6). 669–682. 17 indexed citations
9.
Lei, Ming, Lünan Yan, Jiayin Yang, et al.. (2018). Safety of hepatitis B virus core antigen-positive grafts in liver transplantation: A single-center experience in China. World Journal of Gastroenterology. 24(48). 5525–5536. 15 indexed citations
10.
11.
Tan, Yifei, Li Jiang, Lünan Yan, et al.. (2017). Prognostic nomogram for patients with non-B non-C hepatocellular carcinoma after curative liver resection. International Journal of Surgery. 44. 160–165. 7 indexed citations
12.
Shen, Junyi, Chuan Li, Lvnan Yan, et al.. (2017). Short- and Long-term Outcomes between Young and Older HCC Patients Exceeding The Milan Criteria after Hepatectomy. Annals of Hepatology. 17(1). 134–143. 11 indexed citations
13.
Shen, Junyi, Chuan Li, Tianfu Wen, et al.. (2016). Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomy. Journal of Surgical Research. 209. 102–111. 25 indexed citations
14.
Li, Chuan, Tianfu Wen, Lvnan Yan, et al.. (2016). Liver resection versus liver resection plus TACE for patients with hepatocellular carcinoma beyond Milan criteria. Journal of Surgical Research. 209. 8–16. 17 indexed citations
15.
Peng, Wei, Chuan Li, Tianfu Wen, et al.. (2016). Postoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinoma. Medicine. 95(30). e4160–e4160. 9 indexed citations
16.
Lv, Tao, Li Jiang, Lünan Yan, et al.. (2015). Multiple Tumors Located in the Same Section Are Associated with Better Outcomes After Hepatic Resection for HCC Patients Meeting the Milan Criteria. Journal of Gastrointestinal Surgery. 19(12). 2207–2214. 12 indexed citations
17.
Liu, Fei, Limei Luo, Yonggang Wei, et al.. (2015). Polymorphisms of the CYP1B1 gene and hepatocellular carcinoma risk in a Chinese population. Gene. 564(1). 14–20. 14 indexed citations
18.
Jiang, Li, Lünan Yan, Tianfu Wen, et al.. (2015). Comparison of Outcomes of Hepatic Resection and Radiofrequency Ablation for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the Barcelona-Clinic Liver Cancer Stage A Classification. Journal of the American College of Surgeons. 221(5). 951–961. 32 indexed citations
19.
Shi, Zheng‐Rong, Lünan Yan, Bo Li, et al.. (2010). Evaluation of standard liver volume formulas by right liver living donor liver transplantation. Zhonghua putong waike zazhi. 25(8). 652–655. 1 indexed citations
20.
Yan, L.-N., Biao Li, Tianfu Wen, et al.. (2009). A Significant Expansion of CD8+ CD28− T-Suppressor Cells in Adult-to-Adult Living Donor Liver Transplant Recipients. Transplantation Proceedings. 41(10). 4229–4231. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeo Toshima Breakdown of academic impact, for papers by Kazuki Takeishi Breakdown of academic impact, for papers by Parissa Tabrizian Breakdown of academic impact, for papers by Anne Durnez Breakdown of academic impact, for papers by Hirotaka Tashiro Breakdown of academic impact, for papers by Cheng‐Yuan Hsia Breakdown of academic impact, for papers by Anna Skowrońska Breakdown of academic impact, for papers by Yohei Mano Breakdown of academic impact, for papers by Sherrie Bhoori Breakdown of academic impact, for papers by Delia D’Avola
Rankless by CCL
2026